❤️ New guidelines drop for heart health stuff

The European Society of Cardiology (ESC) released three major guideline updates at ESC Congress 2026. These updates cover cardiac rehabilitation, chronic kidney disease (CKD), and heart failure (HF). The guidelines emphasize broader rehab benefits and require heart patients to be screened for kidney disease. HF guidelines now use a staging approach and rename 'acute' HF to 'decompensated' HF. These changes aim to improve early intervention globally. 🩺

🏏 Ponting says Labuschagne's Test spot is 'untenable'

Ricky Ponting stated that Marnus Labuschagne's position in the Australia Test team is nearly untenable. This comment came while Ponting was speaking to Sky Sports News regarding the Bangladesh series. Labuschagne has scored 1, 31, and 4, and lacks a Test century in 43 innings. Ponting believes changes are inevitable before the South Africa tour starting October 9. The team must look at a replacement at No 3 while planning for future changes.

💧 Andhra's big water project sparks political beef

Andhra Pradesh CM Chandrababu Naidu inaugurated Phase-I of the Veligonda irrigation project, releasing Krishna water into the Nallamala Sagar reservoir. The TDP government stated Phase-I will provide irrigation to 1.19 lakh acres and drinking water to nearly four lakh people. The project's inauguration has triggered a political fight with the YSR Congress Party. YSRCP leaders claim Naidu is taking credit for work done under previous governments. The TDP insists their current administration completed the final hurdles to make the water release possible. 💧

📉 China tightens property rules amid market slump

China has implemented stricter property regulations to curb delivery risks and reduce developer reliance on presales. Local governments are now directed to promote sales of ready-to-move-in housing and boost buyer protections. New rules mandate housing loans only after project completion, while increasing the maximum mortgage tenure to 40 years. This shift forces developers to fund construction internally, impacting their cash flow significantly. The measures aim to stabilize the struggling property market which has faced a downturn since 2020.

🧠 Strict BP Control Lowers Dementia Risk by 15%

A recent trial, the CRHCP, demonstrated that intensive blood pressure control significantly reduces the risk of developing dementia. The study involved participants monitored across various healthcare settings. Specifically, the findings were recorded after monitoring periods concluded on March 15, 2023. This research highlights the critical importance of managing hypertension for brain health preservation. Future studies will likely explore optimized treatment protocols based on these crucial data points.

🤖 AI tools replacing coders? The tech shift is real. 🤖

Software engineers are shifting from typing code to giving verbal instructions to AI agents in Silicon Valley. To cover data-centre costs, AI revenue needs to hit $2.5trn annually by the decade's end, up from $150bn currently. So far, software developers show the strongest adoption, with four-fifths using AI coding tools, and legal/finance are next in line. Coding is uniquely suited because of vast open-source data and easy validation via software tests. AI firms are tackling data gaps using synthetic data and expert consultants.

⚛️ Quantum circuits show advantage with shallow designs ⚛️

Researchers Adam Bene Watts and Natalie Parham demonstrated a clear quantum advantage in sampling from specific probability distributions. This research was conducted at the Institute for Quantum Computing, University of Waterloo, and Columbia University. The study found a logarithmic computational depth difference when sampling Distribution Dn, published in Quantum volume 10, page 2188 on a recent date. This confirms quantum advantage extends to input-independent sampling tasks, addressing a challenge posed by Bravyi, Gosset, and Koenig. This advance hints at near-term quantum capabilities for complex machine learning problems.

📈 Gold holds steady near $4,450 amid Fed uncertainty

Gold prices are currently stabilizing below the $4,450 mark. This movement is being observed globally as traders react to expectations surrounding Federal Reserve interest rate hikes. Specifically, the price action reflects bulls showing some hesitation in the market. The broader context involves market anticipation regarding future monetary policy decisions by the Fed. Investors will continue to watch Fed announcements for further direction in gold's trajectory. 📈

🧠 Why stroke rehab needs to start early in hospital

Stroke rehabilitation must be integrated into the acute care pathway, according to Dr Jayendra Yadav at Fortis Hiranandani Hospital in Vashi, Navi Mumbai. Early functional assessment and multidisciplinary intervention are crucial for better long-term patient outcomes. These outcomes involve safe swallowing, independent movement, and returning to daily life. Early rehab, even small steps, prepares patients and families for the transition home. Hospitals need to coordinate care to build a safe bridge to community reintegration. 🏥

🔬 New vaccine approach targets TB's dangerous proteins

Tuberculosis, a major global killer, is being tackled with a new vaccine candidate designed using immunoinformatic techniques. Researchers developed this multi-epitope subunit vaccine (MESV) targeting five virulence-associated proteins from Mycobacterium tuberculosis. The study involved rigorous testing, confirming the MESV's stability and strong binding affinity to TLR4 receptors. This promising candidate could potentially generate powerful humoral and cellular immune responses against the disease. Further experimental validation is now required to see its real-world impact. 🔬

🚨 AI scribes messing up NHS patient records

AI scribes are reportedly getting drug names and diagnoses wrong in NHS records across England. Healthwatch England reported that these tools, used by GPs and hospital doctors, are making errors that patients often spot. The watchdog found instances where a scribe swapped a drug, omitted instructions, or wrongly recorded a treatment. These issues persist because there is no England-wide oversight classifying the AI scribes as medical devices. The solution suggested is informing patients when a scribe is used and giving them notes to review.